Montelukast added to fluticasone propionate does not alter inflammation or outcomes

Montelukast added to fluticasone propionate does not alter inflammation or outcomes

Background Airway inflammation is a key pathological feature of asthma which underlies its clinical presentation. Objectives To examine whether adding a leukotriene modifier to an inhaled corticosteroid produces further clinical and/or anti-inflammatory benefits in patients symptomatic on short-a...

Full description

Bibliographic Details
Main Authors: Djukanović, Ratko (Author), Wilson, Susan J. (Author), Moore, Wendy C. (Author), Koenig, Steven M. (Author), Laviolette, Michel (Author), Bleecker, Eugene (Author), Davis, W. Bruce (Author), Doherty, Dennis E. (Author), Olivenstein, Ronald (Author), Israel, Elliot (Author), Kavuru, Mani (Author), Kleerup, Eric (Author), Reilly, Donna S. (Author), Yancey, Steven (Author), Edwards, Lisa D. (Author), Stauffer, John L. (Author), Dorinsky, Paul M. (Author), Jarjour, Nizar N. (Author)
Format: Article
Language:English
Published: 2010-10.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items